CAR-T and the Dawn of Immunotherapy

Immunotherapy has become one of the most popular topics of re-search in the biomedical sciences and shown promise in treating can-cer due to its high target specificity and remission rates in clinical tri-als. Current cancer treatments involve transplantation of donor organs, which relies on limited amounts of donors and may result in immune rejection, and drugs, which are highly toxic to the body. However, the potential of the current methods pale in comparison to the prospect of immunotherapy.